Our products are divided into prescription medicines, vaccines and consumer healthcare. We also have two other divisions involved in specific areas of healthcare, ViiV Healthcare and Stiefel.

In March 2015 we completed a 3-part transaction with Novartis which reshapes our business. We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. In addition, Novartis acquired our marketed Oncology portfolio and the R&D activities related to it.

As the integration of this business units progresses, this website will be updated to reflect the expanded portfolio of vaccines and consumer healthcare products.


Find out more

ViiV Healthcare

ViiV Healthcare is an independent company which develops HIV/AIDS medicines. Its flexible way of working means it can quickly respond to the needs of the HIV community. For more information visit


Stiefel focuses on dermatology and has a long track record of innovation in skin health. Today, it offers some of the highest quality prescription and over the counter skin care products available. You can find more details at (Opens in a new window)